AdimrSC-2f
AdimrSC-2f Uses, Dosage, Side Effects, Food Interaction and all others data.
The AdimrSC-2f (SARS-CoV-2) vaccine is developed through Adimmune Corporation, the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia. A phase I study (NCT04522089) will investigate the safety and immunogenicity of the vaccine.
| Trade Name | AdimrSC-2f |
| Generic | AdimrSC-2f |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here AdimrSC-2f
